facebook
twitter
rss
account
search
search
 

Diabetes drug may increase heart risk

June 28, 2010 at 8:13 PM   |   Comments

SILVER SPRING, Md., June 28 (UPI) -- A U.S. study of more than 227,000 patients found those prescribed the diabetes drug Avandia had a higher risk of heart trouble and death, researchers said.

Study leader David J. Graham of the Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration in Silver Spring, Md., and colleagues found compared with Actos, or pioglitazone, Avandia, or rosiglitazone, was associated with an increased risk of adverse cardiovascular events including heart failure and death.

However, Graham said the observational study of Medicare patients with a mean age of 74.4 years was not randomized so the finding may reflect unrecognized biases or confounding.

The findings are published online in the Journal of the American Medical Association.

© 2010 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Richmond hospital patient tests negative for Ebola Richmond hospital patient tests negative for Ebola
2
CDC's Frieden admits uncertainty over Texas Ebola transmission CDC's Frieden admits uncertainty over Texas Ebola transmission
3
Morning exercise helps calm ADHD symptoms in children Morning exercise helps calm ADHD symptoms in children
4
Changing the names of drugs to reflect their effects Changing the names of drugs to reflect their effects
5
Yoga guru BKS Iyengar dies at 95 Yoga guru BKS Iyengar dies at 95
Trending News
Around the Web
x
Feedback